Platelet reactivity is greater in patients with stable angina and with more extensive peripheral vascular atherosclerosis. We sought to evaluate whether impaired peripheral microcirculatory endothelial function might correlate with platelet reactivity after clopidogrel and therefore predispose to an unfavorable outcome after percutaneous coronary intervention (PCI). In 52 consecutive patients with stable angina undergoing elective PCI, endothelial function was assessed by (1) endothelial peripheral arterial tonometry (measuring the "Endoscore"); (2) the von Willebrandt factor antigen level and ristocetin co-factor activity. Basal platelet reactivity was assessed by soluble P-selectin. Patients then received a 600-mg clopidogrel loading dose ≥12 hours before PCI. A blood sample was withdrawn 12 hours later, but before PCI, to assess platelet reactivity using the P2Y12 reaction unit and percentage of P2Y12 inhibition with the point-of-care VerifyNow P2Y12 assay. Troponin T was assessed 24 hours after PCI. The Endoscore inversely correlated with von Willebrandt factor antigen activity (r = -0.52, p = 0.0001) and soluble P-selectin concentration (r = -0.36, p = 0.021), suggesting greater platelet reactivity with increased impaired endothelial function. After clopidogrel, the Endoscore correlated directly with the percentage of P2Y12 inhibition (r = 0.36, p = 0.009) and inversely with the P2Y12 reaction unit (r = -0.41, p = 0.002), suggesting greater residual platelet reactivity with more impaired endothelial function. The average Endoscore was significantly lower in patients with troponin T elevation (troponin positive group 0.267 ± 0.091) than in patients without troponin T elevation (troponin negative group 0.508 ± 0.041, p = 0.015 vs troponin positive). In conclusion, an impaired endothelial response before clopidogrel was associated with greater platelet reactivity after clopidogrel. This link might explain the unfavorable PCI outcomes in patients with more severe endothelial impairment. © 2010 Elsevier Inc. All rights reserved.

Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention / Muller, Olivier; Hamilos, Michalis; Bartunek, Jozef; Ulrichts, Hans; Mangiacapra, Fabio; Holz, Josephine; Ntalianis, Argyrios; Trana, Catalina; Dierickx, Karen; Vercruysse, Kristof; De Bruyne, Bernard; Wijns, William; Barbato, Emanuele. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 105:3(2010), pp. 333-338. [10.1016/j.amjcard.2009.09.033]

Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention

BARBATO, EMANUELE
2010

Abstract

Platelet reactivity is greater in patients with stable angina and with more extensive peripheral vascular atherosclerosis. We sought to evaluate whether impaired peripheral microcirculatory endothelial function might correlate with platelet reactivity after clopidogrel and therefore predispose to an unfavorable outcome after percutaneous coronary intervention (PCI). In 52 consecutive patients with stable angina undergoing elective PCI, endothelial function was assessed by (1) endothelial peripheral arterial tonometry (measuring the "Endoscore"); (2) the von Willebrandt factor antigen level and ristocetin co-factor activity. Basal platelet reactivity was assessed by soluble P-selectin. Patients then received a 600-mg clopidogrel loading dose ≥12 hours before PCI. A blood sample was withdrawn 12 hours later, but before PCI, to assess platelet reactivity using the P2Y12 reaction unit and percentage of P2Y12 inhibition with the point-of-care VerifyNow P2Y12 assay. Troponin T was assessed 24 hours after PCI. The Endoscore inversely correlated with von Willebrandt factor antigen activity (r = -0.52, p = 0.0001) and soluble P-selectin concentration (r = -0.36, p = 0.021), suggesting greater platelet reactivity with increased impaired endothelial function. After clopidogrel, the Endoscore correlated directly with the percentage of P2Y12 inhibition (r = 0.36, p = 0.009) and inversely with the P2Y12 reaction unit (r = -0.41, p = 0.002), suggesting greater residual platelet reactivity with more impaired endothelial function. The average Endoscore was significantly lower in patients with troponin T elevation (troponin positive group 0.267 ± 0.091) than in patients without troponin T elevation (troponin negative group 0.508 ± 0.041, p = 0.015 vs troponin positive). In conclusion, an impaired endothelial response before clopidogrel was associated with greater platelet reactivity after clopidogrel. This link might explain the unfavorable PCI outcomes in patients with more severe endothelial impairment. © 2010 Elsevier Inc. All rights reserved.
2010
clopidogrel; PADGEM protein; ristocetin; troponin T; von Willebrand factor; adverse outcome; aged; angiocardiography; artery; article; assay; atherosclerosis; blood sampling; coronary artery disease; Endoscore; female; human; major clinical study; male; percutaneous coronary intervention; point of care testing; prediction; priority journal; scoring system; stable angina pectoris; thrombocyte; tonometry; treatment outcome; vascular endothelium; Aged; Angina Pectoris; Angioplasty; Transluminal; Percutaneous Coronary; Aspirin; Biological Markers; Blood Platelets; Drug Therapy; Combination; Endothelium; Vascular; Female; Humans; Male; Manometry; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Prospective Studies; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Failure; Treatment Outcome; Troponin T
01 Pubblicazione su rivista::01a Articolo in rivista
Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention / Muller, Olivier; Hamilos, Michalis; Bartunek, Jozef; Ulrichts, Hans; Mangiacapra, Fabio; Holz, Josephine; Ntalianis, Argyrios; Trana, Catalina; Dierickx, Karen; Vercruysse, Kristof; De Bruyne, Bernard; Wijns, William; Barbato, Emanuele. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 105:3(2010), pp. 333-338. [10.1016/j.amjcard.2009.09.033]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1660278
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 33
social impact